Spruce Biosciences, Inc. (NASDAQ:SPRB) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Michael Grey Other companies: OnKure Therapeutics, Inc. (Director · Since at least Apr 8, 2021); Mirum Pharmaceuticals, Inc. (Director · Since at least Jul 17, 2019); Horizon Pharma PLC (Director · Sep 29, 2011 – May 3, 2018 · Past); BioMarin Pharmaceutical Inc. (Director · Dec 14, 2006 – Mar 5, 2021 · Past); Achillion Pharmaceuticals Inc (Director · Oct 25, 2006 – Dec 18, 2009 · Past); Idm Pharma Inc (Director · Jun 14, 2006 – Dec 11, 2008 · Past); SGX Pharmaceuticals Inc (President & CEO, Director · Jan 31, 2006 – Aug 20, 2008 · Past) | Executive Chairman, Director · Since at least Oct 8, 2020 |
| Adrian Quartel Other companies: Zevra Therapeutics, Inc. (Chief Medical Officer · Since at least Dec 6, 2024); Acer Therapeutics Inc (Chief Medical Officer · Feb 21, 2022 – Mar 14, 2023 · Past) | Chief Medical Officer · Since at least Jul 27, 2026 |
| Bali Muralidhar Other companies: Exicure, Inc. (Director · Jun 2, 2021 – Jun 13, 2022 · Past); OnKure Therapeutics, Inc. (Director · Apr 8, 2021 – Jun 6, 2023 · Past) | Director · Since at least Oct 8, 2020 |
| Niall O'Donnell Other companies: OnKure Therapeutics, Inc. (Director · Apr 8, 2021 – Jun 6, 2023 · Past); Mirum Pharmaceuticals, Inc. (Director · Jul 17, 2019 – Nov 11, 2022 · Past) | Director · Oct 8, 2020 – May 25, 2023 · Past |
| Camilla V. Simpson Other companies: GRI Bio, Inc. (Director · Since at least Apr 21, 2023) | Director · Since at least Oct 8, 2020 |
| Moghrabi Dina Chaya Other companies: Imago Biosciences Inc (Director · Jul 15, 2021 – Jan 11, 2023 · Past) | Director · Oct 8, 2020 – May 25, 2022 · Past |
| Samir Gharib Other companies: Talon Therapeutics Inc (Controller, Direct. of Finance · Oct 17, 2011 – Jul 17, 2013 · Past) | President and Chief Financial Officer · Since at least Oct 8, 2020 |
| Tiba Aynechi Other companies: MBX Biosciences, Inc. (Director · Since at least Sep 12, 2024) | Director · Since at least May 22, 2024 |
| Agnieszka Jurecka | Vice President, Medical Affairs · Since at least Jun 22, 2026 |
| Brian Walls | Vice President, Market Access · Since at least May 13, 2026 |
| Bruno Gagnon | Senior Vice President, Clinical Development Operations · Since at least May 13, 2026 |
| Dale Hooks | Chief Commercial Officer · Since at least Mar 9, 2026 |
| Dan Spiegelman | Independent · Since at least Nov 4, 2026 |
| Darren Johnson | Vice President, Commercial Operations · Since at least May 13, 2026 |
| Dash Reddy | Vice President, Pharmaceutical Development and Manufacturing · Since at least Nov 4, 2026 |
| Daven Mody | Senior Vice President, Regulatory and Quality · Since at least May 13, 2026 |
| Douglas Kirk Ways | Interim Chief Medical Officer, Director · Since at least Jun 23, 2021 |
| Eric Jordan | Vice President, Marketing · Since at least Jun 15, 2026 |
| Javier Szwarcberg | CHIEF EXECUTIVE OFFICER, Director · Since at least Jun 30, 2026 |
| Jessica Cohen Pfeffer | Vice President, Clinical Development · Since at least Aug 3, 2026 |
| Jonas Hansson | Director · Oct 8, 2020 – Oct 14, 2020 · Past |
| Keli Walbert | Independent · Since at least Dec 15, 2025 |
| Kirk Ways | Director · Since at least Oct 8, 2026 |
| Percival Barretto-Ko | Independent · Since at least May 25, 2023 |
| Ralph William Charlton III | CHIEF MEDICAL OFFICER · Dec 14, 2023 – Dec 10, 2024 · Past |
| Saba Sile | Senior Vice President, Clinical Development · Since at least Oct 8, 2026 |
| Subaweerage Dias | Chief Medical Officer · Oct 8, 2020 – Dec 16, 2021 · Past |
| Tina Gullotta | Vice President, Finance and Corporate Controller · Since at least Jun 15, 2026 |